Decreased cardiomyocyte proliferation but not increased apoptosis in the compound K51R-Tg/Nkx2.5^+/− mouse hearts. by Eun Young Kim (132204)

Hedgehog signaling is decreased in <i>Foxa1</i>;<i>Foxa2</i> double knockouts. by Jennifer A. Maier (278698)

“…At E9.5, <i>Shh</i> mRNA is found in the brain, midline, and hindgut of control (A) <i>Foxa1</i> null (B) and <i>Foxa2</i> knockout embryos (C). …”

CXCL8 (2, 20, and 200 pg/ml) and CCL20 (5, 50, and 500 pg/ml) enhanced Ki-67 gene expression, but only 200 pg/ml of CXCL8 and 500 pg/ml of CCL20 enhanced early osteogenic marker ge... by Janak L. Pathak (759122)

Glycolytic type 2x, but not type 2b, fibers decrease following muscle regeneration. by Steven J. Foltz (845135)

Hepatic irradiation decreases the proportion of DX5^–TRAIL⁺ lrNK cells for up to two months. by Ryosuke Nakano (4557097)

“…<p>(A) The liver and splenic lymphocytes were stained with anti-NK1.1, anti-TCRβ, and PI. …”

Loss of C1-FDX results in a reduction of the CI and CV activity. by Baoyin Chen (2635399)

Figure 2 The serotonin biosynthetic enzyme TPH-1 is required in chemosensory neurons to inhibit the Dar phenotype and decrease pathogen clearance rates by Rachel Mcmullan (506214)

<i>Atx2</i> knockdown decreases Htt and mHtt levels while Atx2 or Atx2-dPAM overexpression does not affect Htt or mHtt levels prior to aggregation formation. by Fangke Xu (7474448)

Longitudinal YU2 gp120 WT-reactive CD4i IgG binding antibodies elicited in RV144 and RV305 (related to Fig 1). by LaTonya D. Williams (3140490)

TGF-β decreases LPL mRNA expression in macrophages by Scott A. Irvine (26973)

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

ABCC3 overexpression decreases the retention of anti-cancer agents. by Sai A. Balaji (1452556)

Representative western blots for Fig 5. by Gonçalo C. Pereira (9022700)

Subjects:

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

Subjects:

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

Subjects:

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

Subjects:

Levels of ATRX are decreased in the cartilage of <i>Atrx^Col2Cre</i> mice. by Lauren A. Solomon (370382)

VEGFR2/VEGF-A ligand binding decreased ranibizumab and aflibercept mediated CCL2, CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

Total blood cell counts are decreased in the irradiated (2 Gy) groups +/− HU treatment WBCs (A) and lymphocytes (B) at 4 days post-proton radiation exposure are significantly decre... by Jenine K. Sanzari (306909)

“…Average counts +/− SD are expressed as a fraction of the control, n = 3–5. The neutrophil count at 4 days post-proton radiation exposure + HU treatment are significantly decreased, compared to the neutrophil counts observed for the No treatment group (*) and the HU group (#). …”